Results 181 to 190 of about 335,393 (290)

Gut Mycobiota‐Associated Tryptophan Catabolites Protect Against Metabolic Dysfunction‐Associated Steatotic Liver Disease

Advanced Science, EarlyView.
ABSTRACT Accumulating evidence suggests that the intestinal microbiota participates in the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD) through microbiota‐host interaction. However, the beneficial role of commensal mycobiota in MASLD progression remains poorly understood.
Shuping Qiao, Shuangya Fan, Juan Xu, Zhen Xu, Chen Peng, Junxing Qu, Ziqian Bing, Shizhen Zhou, Sunan Shen, Guifang Xu, Yue Zhao, Tingting Wang   +11 more
wiley   +1 more source

Editorial: Advances in medical imaging for precision diagnostic and therapeutic applications in digestive diseases. [PDF]

Front Med (Lausanne)
Shen F, Shi F, Wang H, Sun Y, Ding Y.
europepmc   +1 more source

Diseases of the Digestive System

Academic Medicine, 1944
openaire   +2 more sources

A 3D In Vitro Model of the Human Hepatobiliary Junction

Advanced Science, EarlyView.
A 3D human organoid platform reconstructs the hepatobiliary junction between primary adult hepatocytes and intrahepatic cholangiocytes. These adult hepatobiliary organoids (aHBOs) support directional bile transport from canaliculi to ductule‐like structures, enable quantitative imaging of junction dynamics, and reveal cell‐type‐specific vulnerabilities
Ashley D. Westerfield, Katarzyna A. Grzelak, Katie Katsuyama, Vardhman Kumar, Bess M. Miller, Joa Yun, Jesse Kirkpatrick, David Mankus, Margaret E. Bisher, Abigail K.R. Lytton‐Jean, Z. Gordon Jiang, David D. Lee, Christopher S. Chen, Sangeeta N. Bhatia   +13 more
wiley   +1 more source

Iron-ing Out the Role of Transferrin Receptor in Kidney Development. [PDF]

Kidney360
Gewin LS, Romero MF.
europepmc   +1 more source

Genome‐Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma

Advanced Science, EarlyView.
A genome‐wide microRNA CRISPR screen identifies miR‐18a as a master regulator of cross‐resistance in melanoma. Loss of miR‐18a activates the AJUBA–YAP/Hippo axis to confer BRAFi resistance and enhances THBS1–CD47 interaction to impair CD8+ T cell immunity. hnRNP A1 is identified as an upstream regulator of miR‐18a processing.
Zhao Wang, Haotian Liu, Xueqi Wang, Jianjin Teng, Zihan Zheng, Jingya Zhang, Wanyi Xiao, Qian Liang, Jiaxin Li, Xiaomeng Jia, Xin Feng, Hongzhang Cui, Menghan Luo, Tielong Yang, Liuxing Wu, Ke Zhao, Weilong Yang, Mulin Jun Li, Dandan Huang, Jilong Yang   +19 more
wiley   +1 more source

Drug-Induced Liver Injury From a Novel Antifungal - Olorofim. [PDF]

ACG Case Rep J
Ranade ST, Sharma D, Franco GR, Hsu C, Ghany MG.   +4 more
europepmc   +1 more source

3. Digestive System Diseases 1) the Digestive Tract Diseases

Nihon Naika Gakkai Zasshi, 2008
Enomoto, Shotaro, Oka, Masashi, Yanaoka, Kimihiro, Ichinose, Masao   +3 more
openaire   +2 more sources

Mechanostimulatory Cues Determine Intestinal Fibroblast Fate and Profibrotic Remodeling in a Physiodynamic Human Gut‐on‐a‐Chip

Advanced Science, EarlyView.
A healthy gut barrier shields underlying fibroblasts from luminal shear forces, illustrating that “good fences make good neighbors.” Barrier damage exposes fibroblasts to shear stress, inducing cell death and the emergence of stress‐adapted, profibrotic fibroblasts. Sustained shear exposure promotes the formation of stiff aggregates of mechanoadapative
Soyoun Min, Nam Than, Yong Cheol Shin, Elif G. Ertugral, Chandrasekhar R. Kothapalli, Olumuyiwa Awoniyi, Hyun Jung Kim   +6 more
wiley   +1 more source

Hyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis and Its Mechanisms (DREAM) Study. [PDF]

Diabetes Care
Dungan KM, Chinchilli VM, Pichardo-Lowden A, Raja-Khan N, Bellin MD, Yadav D, Hart PA, Basina M, Buxbaum JL, Casu A, Evans-Molina C, Conwell DL, Fogel EL, Forsmark CE, Goodarzi MO, Kalyani RR, Layden BT, Lord SM, Papachristou GI, Park WG, Pratley R, Singh VK, Speake C, Trikudanathan G, Laughlin M, Toledo FGS, Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)*.   +26 more
europepmc   +1 more source